2024 Q1 Form 10-K Financial Statement

#000176068924000007 Filed on April 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $81.35M $104.6M $306.6M
YoY Change 73.19% 61.39% 49.94%
Cost Of Revenue $64.13M $81.55M $249.4M
YoY Change 52.26% 30.33% 27.62%
Gross Profit $17.23M $23.02M $57.23M
YoY Change 254.57% 934.32% 530.74%
Gross Profit Margin 21.17% 22.02% 18.66%
Selling, General & Admin $29.39M $34.64M $120.9M
YoY Change 15.81% 29.29% -4.94%
% of Gross Profit 170.6% 150.46% 211.27%
Research & Development $11.49M $11.40M $45.00M
YoY Change 5.81% 8.54% 3.44%
% of Gross Profit 66.72% 49.49% 78.64%
Depreciation & Amortization $7.591M $7.620M $22.63M
YoY Change 48.93% 59.28% 11.14%
% of Gross Profit 44.07% 33.1% 39.55%
Operating Expenses $40.88M $46.04M $165.9M
YoY Change 12.81% 23.45% -2.8%
Operating Profit -$23.12M -$23.01M -$106.7M
YoY Change -26.14% -34.37% -33.27%
Interest Expense $1.732M -$1.063M $2.628M
YoY Change 277.34% -237.16% -20.91%
% of Operating Profit
Other Income/Expense, Net -$136.0K -$1.302M -$713.0K
YoY Change -117.24% -800.0% -175.53%
Pretax Income -$24.83M -$24.58M -$106.4M
YoY Change -16.05% -26.98% -32.73%
Income Tax $0.00 $10.00K $10.00K
% Of Pretax Income
Net Earnings -$24.83M -$24.54M -$106.3M
YoY Change -16.08% -27.19% -32.78%
Net Earnings / Revenue -30.52% -23.46% -34.68%
Basic Earnings Per Share -$0.08 -$0.34
Diluted Earnings Per Share -$0.08 -$0.08 -$0.34
COMMON SHARES
Basic Shares Outstanding 317.2M shares 316.5M shares 310.9M shares
Diluted Shares Outstanding 315.4M shares 310.9M shares

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $39.45M $50.18M $50.18M
YoY Change -82.51% -80.44% -80.44%
Cash & Equivalents $39.45M $44.54M $44.54M
Short-Term Investments $0.00 $5.634M $5.634M
Other Short-Term Assets $65.67M $63.23M $48.20M
YoY Change -10.82% -21.07% -39.83%
Inventory $137.3M $149.7M $149.7M
Prepaid Expenses
Receivables $123.5M $138.7M $162.5M
Other Receivables $0.00 $0.00 $15.03M
Total Short-Term Assets $378.2M $425.6M $425.6M
YoY Change -23.92% -21.92% -21.92%
LONG-TERM ASSETS
Property, Plant & Equipment $616.5M $620.7M $640.2M
YoY Change 39.15% 85.2% 82.12%
Goodwill
YoY Change
Intangibles $2.985M $3.136M
YoY Change -19.13% 91.69%
Long-Term Investments
YoY Change
Other Assets $9.954M $9.661M $27.82M
YoY Change -65.81% -86.88% -67.93%
Total Long-Term Assets $662.5M $671.1M $671.1M
YoY Change 30.68% 52.57% 52.57%
TOTAL ASSETS
Total Short-Term Assets $378.2M $425.6M $425.6M
Total Long-Term Assets $662.5M $671.1M $671.1M
Total Assets $1.041B $1.097B $1.097B
YoY Change 3.65% 11.35% 11.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $83.07M $112.6M $112.6M
YoY Change 101.42% 150.35% 150.35%
Accrued Expenses $27.18M $30.51M $30.51M
YoY Change 164.46% 34.78% 34.78%
Deferred Revenue $41.28M $43.09M
YoY Change -22.21% -20.51%
Short-Term Debt $41.03M $35.39M $98.77M
YoY Change 87.87% 103.43% 15.06%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $366.6M $403.4M $403.4M
YoY Change 31.99% 59.82% 59.82%
LONG-TERM LIABILITIES
Long-Term Debt $86.19M $86.92M $86.92M
YoY Change 18.05% 19.25% 19.25%
Other Long-Term Liabilities $25.24M $24.86M $42.21M
YoY Change -19.41% -22.51% -9.58%
Total Long-Term Liabilities $25.24M $24.86M $129.1M
YoY Change -19.41% -22.51% 8.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $366.6M $403.4M $403.4M
Total Long-Term Liabilities $25.24M $24.86M $129.1M
Total Liabilities $494.5M $532.5M $532.5M
YoY Change 24.2% 43.16% 43.16%
SHAREHOLDERS EQUITY
Retained Earnings -$922.3M -$897.5M
YoY Change 12.38% 13.44%
Common Stock $32.00K $32.00K
YoY Change 3.23% 3.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $546.1M $564.2M $564.2M
YoY Change
Total Liabilities & Shareholders Equity $1.041B $1.097B $1.097B
YoY Change 3.65% 11.35% 11.35%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$24.83M -$24.54M -$106.3M
YoY Change -16.08% -27.19% -32.78%
Depreciation, Depletion And Amortization $7.591M $7.620M $22.63M
YoY Change 48.93% 59.28% 11.14%
Cash From Operating Activities $2.031M -$4.953M -$75.30M
YoY Change -118.19% -206.13% 39.64%
INVESTING ACTIVITIES
Capital Expenditures $10.24M $33.21M $186.8M
YoY Change -71.49% -49.8% 23.8%
Acquisitions
YoY Change
Other Investing Activities $5.716M $20.73M $21.18M
YoY Change 5792.78% -182.69% -184.51%
Cash From Investing Activities -$4.525M -$12.48M -$165.6M
YoY Change -87.37% -86.31% -5.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $6.260M 20.89M $33.04M
YoY Change 42.79% -171.39% 565.21%
NET CHANGE
Cash From Operating Activities $2.031M -4.953M -$75.30M
Cash From Investing Activities -$4.525M -12.48M -$165.6M
Cash From Financing Activities $6.260M 20.89M $33.04M
Net Change In Cash -$1.485M 3.450M -$214.4M
YoY Change -96.48% -102.98% -8.16%
FREE CASH FLOW
Cash From Operating Activities $2.031M -$4.953M -$75.30M
Capital Expenditures $10.24M $33.21M $186.8M
Free Cash Flow -$8.210M -$38.17M -$262.1M
YoY Change -82.56% -37.93% 27.97%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
12603 Southwest Freeway
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
231420000 usd
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
25070000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4407000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12093000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
425606000 usd
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
6171000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
620667000 usd
CY2023Q4 mvst Land Use Rights Net
LandUseRightsNet
11984000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3136000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19507000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9661000 usd
CY2023Q4 us-gaap Assets
Assets
1096732000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
112618000 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
63374000 usd
CY2023Q4 mvst Accrued Expense And Other Liabilities Current
AccruedExpenseAndOtherLiabilitiesCurrent
148284000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
43087000 usd
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
35392000 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
655000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
403410000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
43761000 usd
CY2023Q4 mvst Long Term Bonds Payables
LongTermBondsPayables
43157000 usd
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
67000 usd
CY2023Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
199000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
17087000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
24861000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
532542000 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
316694442 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
315006942 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
32000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1481241000 usd
CY2023Q4 us-gaap Statutory Accounting Practices Statutory Capital And Surplus Balance
StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
6032000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-897501000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-25614000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
564190000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1096732000 usd
CY2022 us-gaap Revenues
Revenues
204495000 usd
CY2023 us-gaap Revenues
Revenues
306617000 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
249390000 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
170691000 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
165909000 usd
CY2022 mvst Subsidy Income
SubsidyIncome
1672000 usd
CY2023 mvst Subsidy Income
SubsidyIncome
1953000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-159946000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-106729000 usd
CY2022 mvst Interest Income
InterestIncome
3179000 usd
CY2023 mvst Interest Income
InterestIncome
3609000 usd
CY2022 us-gaap Interest Expense
InterestExpense
3323000 usd
CY2023 us-gaap Interest Expense
InterestExpense
2628000 usd
CY2022 mvst Gain Loss On Changes In Fair Value Of Convertible Notes
GainLossOnChangesInFairValueOfConvertibleNotes
0 usd
CY2023 mvst Gain Loss On Changes In Fair Value Of Convertible Notes
GainLossOnChangesInFairValueOfConvertibleNotes
0 usd
CY2022 mvst Gain On Change In Fair Value Of Warrant Liability
GainOnChangeInFairValueOfWarrantLiability
979000 usd
CY2023 mvst Gain On Change In Fair Value Of Warrant Liability
GainOnChangeInFairValueOfWarrantLiability
59000 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
944000 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-713000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-158167000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-106402000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
33000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
612977000 usd
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.26
CY2022 us-gaap Profit Loss
ProfitLoss
-158200000 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-106412000 usd
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-7621000 usd
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-59000 usd
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
303279188 shares
CY2022 mvst Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
19375000 usd
CY2023 mvst Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
5446000 usd
CY2021 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
2135000 usd
CY2022 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
282000 usd
CY2021 mvst Increase Decrease In Notes Payable
IncreaseDecreaseInNotesPayable
24159000 usd
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001760689
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201613Member
CY2023 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201613Member
CY2022Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://thcb.com/20231231#AccruedExpenseAndOtherLiabilitiesCurrent
CY2023Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://thcb.com/20231231#AccruedExpenseAndOtherLiabilitiesCurrent
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity Registrant Name
EntityRegistrantName
Microvast Holdings, Inc.
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-2530757
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 300
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Stafford
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77477
CY2023 dei City Area Code
CityAreaCode
(281)
CY2023 dei Local Phone Number
LocalPhoneNumber
491-9505
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
false
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
354000000 usd
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
317206095 shares
CY2023 dei Auditor Name
AuditorName
Deloitte Touche Tohmatsu Certified Public Accountants LLP
CY2023 dei Auditor Location
AuditorLocation
Beijing, the People’s Republic of China
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
44541000 usd
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
70732000 usd
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
37477000 usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
5634000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4571000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
119304000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
138717000 usd
CY2022Q4 mvst Note Receivables Net Current
NoteReceivablesNetCurrent
2196000 usd
CY2023Q4 mvst Note Receivables Net Current
NoteReceivablesNetCurrent
23736000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
84252000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
149749000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
25752000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
545067000 usd
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
465000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
335140000 usd
CY2022Q4 mvst Land Use Rights Net
LandUseRightsNet
12639000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1636000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16368000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
73642000 usd
CY2022Q4 us-gaap Assets
Assets
984957000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
44985000 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
68441000 usd
CY2022Q4 mvst Accrued Expense And Other Liabilities Current
AccruedExpenseAndOtherLiabilitiesCurrent
66720000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
54207000 usd
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
17398000 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
658000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
252409000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
28997000 usd
CY2022Q4 mvst Long Term Bonds Payables
LongTermBondsPayables
43888000 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
126000 usd
CY2022Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
131000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14347000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
32082000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
371980000 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
309316011 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
307628511 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
31000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1416160000 usd
CY2022Q4 us-gaap Statutory Accounting Practices Statutory Capital And Surplus Balance
StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
6032000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-791165000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-18081000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
612977000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
984957000 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
34385000 usd
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
21431000 usd
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
22611000 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
157448000 usd
CY2021 mvst Subsidy Income
SubsidyIncome
6127000 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-194064000 usd
CY2021 mvst Interest Income
InterestIncome
446000 usd
CY2021 us-gaap Interest Expense
InterestExpense
5411000 usd
CY2021 mvst Gain Loss On Changes In Fair Value Of Convertible Notes
GainLossOnChangesInFairValueOfConvertibleNotes
-9861000 usd
CY2021 mvst Gain On Change In Fair Value Of Warrant Liability
GainOnChangeInFairValueOfWarrantLiability
2469000 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-62000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-206483000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10000 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-206483000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-158200000 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-106412000 usd
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-76000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-206483000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-158200000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-106336000 usd
CY2021 mvst Less Accretion Of Series C1 Preferred
LessAccretionOfSeriesC1Preferred
2257000 usd
CY2022 mvst Less Accretion Of Series C1 Preferred
LessAccretionOfSeriesC1Preferred
0 usd
CY2023 mvst Less Accretion Of Series C1 Preferred
LessAccretionOfSeriesC1Preferred
0 usd
CY2021 mvst Less Accretion Of Series C2 Preferred Stock
LessAccretionOfSeriesC2PreferredStock
5132000 usd
CY2022 mvst Less Accretion Of Series C2 Preferred Stock
LessAccretionOfSeriesC2PreferredStock
0 usd
CY2023 mvst Less Accretion Of Series C2 Preferred Stock
LessAccretionOfSeriesC2PreferredStock
0 usd
CY2021 mvst Less Accretion Of Series D1 Preferred
LessAccretionOfSeriesD1Preferred
10708000 usd
CY2022 mvst Less Accretion Of Series D1 Preferred
LessAccretionOfSeriesD1Preferred
0 usd
CY2023 mvst Less Accretion Of Series D1 Preferred
LessAccretionOfSeriesD1Preferred
0 usd
CY2021 mvst Less Accretion For Noncontrolling Interests
LessAccretionForNoncontrollingInterests
9523000 usd
CY2022 mvst Less Accretion For Noncontrolling Interests
LessAccretionForNoncontrollingInterests
0 usd
CY2023 mvst Less Accretion For Noncontrolling Interests
LessAccretionForNoncontrollingInterests
0 usd
CY2021 mvst Net Loss Attributable To Ordinary Shareholders Of Microvast Inc
NetLossAttributableToOrdinaryShareholdersOfMicrovastInc
-234103000 usd
CY2022 mvst Net Loss Attributable To Ordinary Shareholders Of Microvast Inc
NetLossAttributableToOrdinaryShareholdersOfMicrovastInc
-158200000 usd
CY2023 mvst Net Loss Attributable To Ordinary Shareholders Of Microvast Inc
NetLossAttributableToOrdinaryShareholdersOfMicrovastInc
-106336000 usd
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
185896482 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
185896482 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
310909379 shares
CY2021 us-gaap Profit Loss
ProfitLoss
-206483000 usd
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-655000 usd
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-24782000 usd
CY2021 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-207138000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-182982000 usd
CY2023 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-114033000 usd
CY2021 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 usd
CY2022 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 usd
CY2023 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-164000 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-207138000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-182982000 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-113869000 usd
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-384602000 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-206483000 usd
CY2021 mvst Accretion For Series C1 Preferred
AccretionForSeriesC1Preferred
-2257000 usd
CY2021 mvst Accretion For Series C2 Preferred
AccretionForSeriesC2Preferred
-5132000 usd
CY2021 mvst Accretion For Series D1 Preferred
AccretionForSeriesD1Preferred
-10708000 usd
CY2021 mvst Accretion For Redeemable Noncontrolling Interest
AccretionForRedeemableNoncontrollingInterest
-5841000 usd
CY2021 mvst Accretion For The Exiting Noncontrolling Interests
AccretionForTheExitingNoncontrollingInterests
-3682000 usd
CY2021 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1241851000 usd
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
39533000 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
24674000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
686698000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
686698000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-158200000 usd
CY2022 mvst Issuance Of Common Stock In Connection With Vesting Of Restricted Stock Units And Stock Options
IssuanceOfCommonStockInConnectionWithVestingOfRestrictedStockUnitsAndStockOptions
0 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
110127000 usd
CY2022 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-24782000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
612977000 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-106412000 usd
CY2023 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
2174000 usd
CY2023 us-gaap Noncontrolling Interest Decrease From Deconsolidation
NoncontrollingInterestDecreaseFromDeconsolidation
2174000 usd
CY2023 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
65246000 usd
CY2023 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-7621000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
564190000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-158200000 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-106412000 usd
CY2021 mvst Gain Loss On Disposal Of Property Plant And Equipment
GainLossOnDisposalOfPropertyPlantAndEquipment
13000 usd
CY2022 mvst Gain Loss On Disposal Of Property Plant And Equipment
GainLossOnDisposalOfPropertyPlantAndEquipment
-14000 usd
CY2023 mvst Gain Loss On Disposal Of Property Plant And Equipment
GainLossOnDisposalOfPropertyPlantAndEquipment
1947000 usd
CY2021 us-gaap Depreciation Nonproduction
DepreciationNonproduction
19975000 usd
CY2022 us-gaap Depreciation Nonproduction
DepreciationNonproduction
19811000 usd
CY2023 us-gaap Depreciation Nonproduction
DepreciationNonproduction
22141000 usd
CY2021 mvst Amortization Of Land Use Rights And Intangible Assets
AmortizationOfLandUseRightsAndIntangibleAssets
738000 usd
CY2022 mvst Amortization Of Land Use Rights And Intangible Assets
AmortizationOfLandUseRightsAndIntangibleAssets
554000 usd
CY2023 mvst Amortization Of Land Use Rights And Intangible Assets
AmortizationOfLandUseRightsAndIntangibleAssets
787000 usd
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
0 usd
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2214000 usd
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2764000 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
82894000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
90808000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
64971000 usd
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2469000 usd
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-979000 usd
CY2021 mvst Changes In Fair Value Of Bridge Notes
ChangesInFairValueOfBridgeNotes
9861000 usd
CY2022 mvst Changes In Fair Value Of Bridge Notes
ChangesInFairValueOfBridgeNotes
0 usd
CY2023 mvst Changes In Fair Value Of Bridge Notes
ChangesInFairValueOfBridgeNotes
0 usd
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
721000 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1640000 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
236000 usd
CY2021 mvst Provision For Obsolete Inventories
ProvisionForObsoleteInventories
18295000 usd
CY2022 mvst Provision For Obsolete Inventories
ProvisionForObsoleteInventories
4789000 usd
CY2023 mvst Provision For Obsolete Inventories
ProvisionForObsoleteInventories
3613000 usd
CY2021 mvst Impairment Loss From Property Plant And Equipments
ImpairmentLossFromPropertyPlantAndEquipments
2443000 usd
CY2022 mvst Impairment Loss From Property Plant And Equipments
ImpairmentLossFromPropertyPlantAndEquipments
1798000 usd
CY2023 mvst Impairment Loss From Property Plant And Equipments
ImpairmentLossFromPropertyPlantAndEquipments
504000 usd
CY2021 us-gaap Product Warranty Expense
ProductWarrantyExpense
52932000 usd
CY2022 us-gaap Product Warranty Expense
ProductWarrantyExpense
14097000 usd
CY2023 us-gaap Product Warranty Expense
ProductWarrantyExpense
12688000 usd
CY2021 us-gaap Increase Decrease In Notes Receivables
IncreaseDecreaseInNotesReceivables
-10016000 usd
CY2022 us-gaap Increase Decrease In Notes Receivables
IncreaseDecreaseInNotesReceivables
-3187000 usd
CY2023 us-gaap Increase Decrease In Notes Receivables
IncreaseDecreaseInNotesReceivables
25338000 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11844000 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
38924000 usd
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
25892000 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
14291000 usd
CY2021 us-gaap Increase Decrease In Due To Other Related Parties
IncreaseDecreaseInDueToOtherRelatedParties
-84000 usd
CY2022 us-gaap Increase Decrease In Due To Other Related Parties
IncreaseDecreaseInDueToOtherRelatedParties
85000 usd
CY2023 us-gaap Increase Decrease In Due To Other Related Parties
IncreaseDecreaseInDueToOtherRelatedParties
0 usd
CY2021 mvst Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
0 usd
CY2023 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
547000 usd
CY2022 mvst Increase Decrease In Notes Payable
IncreaseDecreaseInNotesPayable
13490000 usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2499000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
7146000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
68576000 usd
CY2023 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-10949000 usd
CY2022 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-24674000 usd
CY2023 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
6602000 usd
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0 usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
14999000 usd
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
2266000 usd
CY2021 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
2218000 usd
CY2022 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
946000 usd
CY2023 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
316000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-45039000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-53928000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-75303000 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
87862000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
150880000 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
186788000 usd
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
5000 usd
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1649000 usd
CY2021 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 usd
CY2022 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
25070000 usd
CY2023 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
5966000 usd
CY2021 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0 usd
CY2022 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0 usd
CY2023 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
25500000 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-87862000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-175945000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-165605000 usd
CY2021 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
38926000 usd
CY2022 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
58708000 usd
CY2023 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
47852000 usd
CY2021 mvst Repayments Of Bonds Payable
RepaymentsOfBondsPayable
0 usd
CY2022 mvst Repayments Of Bonds Payable
RepaymentsOfBondsPayable
29259000 usd
CY2023 mvst Repayments Of Bonds Payable
RepaymentsOfBondsPayable
692000 usd
CY2021 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
37568000 usd
CY2022 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
24482000 usd
CY2023 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
14119000 usd
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
8426000 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
CY2021 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
8426000 usd
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 usd
CY2023 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 usd
CY2021 mvst Cash Received From The Trust Account Upon Merger Net Of Transaction Costs Note
CashReceivedFromTheTrustAccountUponMergerNetOfTransactionCostsNote
222629000 usd
CY2022 mvst Cash Received From The Trust Account Upon Merger Net Of Transaction Costs Note
CashReceivedFromTheTrustAccountUponMergerNetOfTransactionCostsNote
0 usd
CY2023 mvst Cash Received From The Trust Account Upon Merger Net Of Transaction Costs Note
CashReceivedFromTheTrustAccountUponMergerNetOfTransactionCostsNote
0 usd
CY2021 mvst Cash Received From Private Investment In Public Equity Pipe Investors Upon Merger
CashReceivedFromPrivateInvestmentInPublicEquityPIPEInvestorsUponMerger
482500000 usd
CY2022 mvst Cash Received From Private Investment In Public Equity Pipe Investors Upon Merger
CashReceivedFromPrivateInvestmentInPublicEquityPIPEInvestorsUponMerger
0 usd
CY2023 mvst Cash Received From Private Investment In Public Equity Pipe Investors Upon Merger
CashReceivedFromPrivateInvestmentInPublicEquityPIPEInvestorsUponMerger
0 usd
CY2021 us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
-139038000 usd
CY2022 us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
0 usd
CY2023 us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
0 usd
CY2021 mvst Issuance Of Bridge Notes
IssuanceOfBridgeNotes
57500000 usd
CY2022 mvst Issuance Of Bridge Notes
IssuanceOfBridgeNotes
0 usd
CY2023 mvst Issuance Of Bridge Notes
IssuanceOfBridgeNotes
0 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
624949000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4967000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
33041000 usd
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2865000 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-8586000 usd
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-6561000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
494913000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-233492000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-214428000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
41196000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
536109000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
302617000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
536109000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
302617000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
88189000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
480931000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
44541000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
55178000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
71197000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
43648000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
536109000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
302617000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
88189000 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
2686000 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
5135000 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
4373000 usd
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2021Q4 mvst Payable For Purchase Of Property Plant And Equipment
PayableForPurchaseOfPropertyPlantAndEquipment
18500000 usd
CY2022Q4 mvst Payable For Purchase Of Property Plant And Equipment
PayableForPurchaseOfPropertyPlantAndEquipment
29183000 usd
CY2023Q4 mvst Payable For Purchase Of Property Plant And Equipment
PayableForPurchaseOfPropertyPlantAndEquipment
96350000 usd
CY2023 us-gaap Nature Of Operations
NatureOfOperations
<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Microvast, Inc. was incorporated under the laws of the State of Texas in the United States of America on October 12, 2006 and re-domiciled to the State of Delaware on December 31, 2015. On July 23, 2021 (the “Closing Date”), Microvast, Inc. and Tuscan Holdings Corp.(“Tuscan”) consummated the previously announced merger (the “Merger” or the "Business Combination"), pursuant to the Agreement and Plan of Merger (the “Merger Agreement”) dated February 1, 2021, between Tuscan, Microvast, Inc. and TSCN Merger Sub Inc., a Delaware corporation (“Merger Sub”).</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, the Merger Sub merged with and into Microvast, Inc., with Microvast, Inc. surviving the Merger. As a result of the Merger, Tuscan was renamed “Microvast Holdings, Inc.” (the “Company”). The Merger was accounted for as a reverse recapitalization as Microvast, Inc. was determined to be the accounting acquirer under Financial Accounting Standards Board’s Accounting Standards Codification Topic 805, Business Combinations (“ASC 805”). Please refer to Note 3 “Reverse Recapitalization” for further details of the Merger.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the completion of the Merger transaction between Microvast, Inc. and Tuscan, the share, per share value and net loss per share available to Microvast Inc.’s common stockholders in the financial statements for each of the year ended December 31, 2021 were retroactively recast to reflect the exchange ratio established in the Merger Agreement. Refer to Note 3 for details.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023, details of the Company’s major subsidiaries are as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.172%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.172%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Subsidiaries</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Place of incorporation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Date of <br/>incorporation <br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Percentage <br/>of ownership</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Microvast, Inc. (“</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Microvast</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">”)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Delaware, USA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">October 2006</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">100 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Microvast Power Solutions, Inc (“</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">MP Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">”)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Texas, USA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">July 2013</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">100 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Microvast Power Systems Co., Ltd. (“</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">MPS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">”)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Huzhou, PRC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">December 2006</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">100 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Microvast GmbH (“</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">MV GmbH</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">”)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Germany</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">May 2016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">100 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Huzhou Hongwei New Energy Automobile Co., Ltd. (“</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Hongwei</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">”)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Huzhou, PRC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">December 2016</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">100 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Microvast Energy, Inc. (“</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MV Energy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">”)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Colorado, USA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">July 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">100 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its subsidiaries (collectively, the “Group”) are primarily engaged in developing, manufacturing, and selling lithium-ion battery technologies for use in commercial electric vehicles and battery energy storage systems across the globe.</span></div>
CY2023 us-gaap Revenues
Revenues
306617000 usd
CY2022 us-gaap Revenues
Revenues
204495000 usd
CY2021 us-gaap Revenues
Revenues
151976000 usd
CY2023 us-gaap Gross Profit
GrossProfit
57227000 usd
CY2022 us-gaap Gross Profit
GrossProfit
9073000 usd
CY2021 us-gaap Gross Profit
GrossProfit
-42743000 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-106412000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-158200000 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-206483000 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-106412000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-158200000 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-206483000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-75303000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-53928000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-45039000 usd
CY2023Q4 mvst Working Capital
WorkingCapital
22196000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
564190000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-897501000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
44541000 usd
CY2023Q4 mvst Bank Borrowings Ending Balance
BankBorrowingsEndingBalance
79153000 usd
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
35392000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
368018000 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenue, costs and expenses in the consolidated financial statements and accompanying notes, and disclosure of contingent liabilities at the date of the consolidated financial statements. Actual results could differ from these estimates. Significant accounting estimates reflected in the Group’s financial statements include allowance for credit losses, provision for obsolete inventories, impairment of long-lived assets, valuation allowance for deferred tax assets, product warranties, fair value measurement of Bridge Notes, fair value measurement of warrant liability and share based compensation.</span></div>
CY2022Q4 mvst Balance Of Notes Receivable
BalanceOfNotesReceivable
2196000 usd
CY2023Q4 mvst Balance Of Notes Receivable
BalanceOfNotesReceivable
23736000 usd
CY2021 us-gaap Interest Income Other
InterestIncomeOther
0 usd
CY2022 us-gaap Interest Income Other
InterestIncomeOther
70000 usd
CY2023 us-gaap Interest Income Other
InterestIncomeOther
438000 usd
CY2023 mvst Estimated Useful Life Term
EstimatedUsefulLifeTerm
P50Y
CY2021 mvst Revenue Related To Contract Balance
RevenueRelatedToContractBalance
1455000 usd
CY2022 mvst Revenue Related To Contract Balance
RevenueRelatedToContractBalance
1151000 usd
CY2023 mvst Revenue Related To Contract Balance
RevenueRelatedToContractBalance
2492000 usd
CY2021 mvst Amortized Deferred Subsidy
AmortizedDeferredSubsidy
269000 usd
CY2022 mvst Amortized Deferred Subsidy
AmortizedDeferredSubsidy
538000 usd
CY2023 mvst Amortized Deferred Subsidy
AmortizedDeferredSubsidy
390000 usd
CY2022Q4 mvst Deferred Subsidy Income
DeferredSubsidyIncome
542000 usd
CY2023Q4 mvst Deferred Subsidy Income
DeferredSubsidyIncome
531000 usd
CY2022Q4 mvst Deferred Non Current Portion
DeferredNonCurrentPortion
3066000 usd
CY2023Q4 mvst Deferred Non Current Portion
DeferredNonCurrentPortion
3382000 usd
CY2021 mvst Purchase Percentage
PurchasePercentage
0.12
CY2022 mvst Purchase Percentage
PurchasePercentage
0.18
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18826000 usd
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
18776000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19507000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
19500000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2413000 usd
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of credit risk</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially expose the Group to concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash, accounts receivable, notes receivable and short-term investments. The Group places its cash and cash equivalents with financial institutions with high credit ratings and quality. The Group conducts credit evaluations of customers and generally does not require collateral or other security from its customers.</span></div>
mvst Net Revenues Percentage
NetRevenuesPercentage
0.10
CY2022Q4 mvst Percentage Of Accounts Receivable
PercentageOfAccountsReceivable
0.10
CY2023Q4 mvst Percentage Of Accounts Receivable
PercentageOfAccountsReceivable
0.10
CY2023 mvst Purchase Percentage
PurchasePercentage
0.15
CY2021Q3 mvst Existing Microvast Equity Holders
ExistingMicrovastEquityHolders
209999991 shares
CY2021Q3 mvst Existing Microvast Convertible Noteholders In Shares
ExistingMicrovastConvertibleNoteholdersInShares
6736106 shares
CY2021Q3 mvst Tuscan Public Stockholders
TuscanPublicStockholders
27493140 shares
CY2021Q3 mvst Sponsor Group In Shares
SponsorGroupInShares
7608589 shares
CY2021Q3 mvst Early Bird Capital
EarlyBirdCapital
428411 shares
CY2021Q3 mvst Shares Outstanding Pipe Investors Immediately After Merger
SharesOutstandingPIPEInvestorsImmediatelyAfterMerger
48250000 shares
CY2021Q3 mvst Common Stock
CommonStock
300516237 shares
CY2021Q3 mvst Shares Subject To Cancellation
SharesSubjectToCancellation
1687500 shares
CY2021Q3 us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
705129000 usd
CY2021Q3 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
281726000 usd
CY2021Q3 us-gaap Financing Receivable Revolving
FinancingReceivableRevolving
58175000 usd
CY2021Q3 mvst Reverse Recapitalization Escrow Shares
ReverseRecapitalizationEscrowShares
1687500 shares
CY2021Q3 mvst Reverse Recapitalization Contingent Consideration Cancellation Period Escrow Share Percentage
ReverseRecapitalizationContingentConsiderationCancellationPeriodEscrowSharePercentage
0.50
CY2021Q3 mvst Reverse Recapitalization Escrow Shares
ReverseRecapitalizationEscrowShares
1687500 shares
CY2021Q3 mvst Reverse Recapitalization Contingent Consideration Cancellation Period Escrow Share Percentage
ReverseRecapitalizationContingentConsiderationCancellationPeriodEscrowSharePercentage
0.50
CY2021Q3 mvst Reverse Recapitalization Escrow Shares
ReverseRecapitalizationEscrowShares
1687500 shares
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
123711000 usd
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
143288000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4407000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4571000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
119304000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
138717000 usd
CY2020Q4 mvst Allowance For Doubtful Account Receivable
AllowanceForDoubtfulAccountReceivable
5047000 usd
CY2021Q4 mvst Allowance For Doubtful Account Receivable
AllowanceForDoubtfulAccountReceivable
5005000 usd
CY2022Q4 mvst Allowance For Doubtful Account Receivable
AllowanceForDoubtfulAccountReceivable
4407000 usd
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
721000 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1640000 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
236000 usd
CY2021 mvst Accounts Receivable Write Off
AccountsReceivableWriteOff
849000 usd
CY2022 mvst Accounts Receivable Write Off
AccountsReceivableWriteOff
2631000 usd
CY2023 mvst Accounts Receivable Write Off
AccountsReceivableWriteOff
128000 usd
CY2021 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
0 usd
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
0 usd
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
121000 usd
CY2021 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
86000 usd
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
-473000 usd
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
-65000 usd
CY2021Q4 mvst Allowance For Doubtful Account Receivable
AllowanceForDoubtfulAccountReceivable
5005000 usd
CY2022Q4 mvst Allowance For Doubtful Account Receivable
AllowanceForDoubtfulAccountReceivable
4407000 usd
CY2023Q4 mvst Allowance For Doubtful Account Receivable
AllowanceForDoubtfulAccountReceivable
4571000 usd
CY2023Q4 mvst Cost Of Land Use Rights
CostOfLandUseRights
14711000 usd
CY2022Q4 mvst Land Use Rights Accumulated Amortization
LandUseRightsAccumulatedAmortization
2504000 usd
CY2023Q4 mvst Land Use Rights Accumulated Amortization
LandUseRightsAccumulatedAmortization
2727000 usd
CY2022Q4 mvst Land Use Rights Net
LandUseRightsNet
12639000 usd
CY2023Q4 mvst Land Use Rights Net
LandUseRightsNet
11984000 usd
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
48747000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
86379000 usd
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
29331000 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
35867000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
6174000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
27503000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
84252000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
149749000 usd
CY2021 us-gaap Inventory Write Down
InventoryWriteDown
18295000 usd
CY2022 us-gaap Inventory Write Down
InventoryWriteDown
4789000 usd
CY2023 us-gaap Inventory Write Down
InventoryWriteDown
3613000 usd
CY2022Q4 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
2408000 usd
CY2023Q4 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
14279000 usd
CY2022Q4 us-gaap Supplies
Supplies
5075000 usd
CY2023Q4 us-gaap Supplies
Supplies
5800000 usd
CY2022Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
3374000 usd
CY2023Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
3972000 usd
CY2022Q4 us-gaap Deposit Assets
DepositAssets
925000 usd
CY2023Q4 us-gaap Deposit Assets
DepositAssets
950000 usd
CY2022Q4 us-gaap Other Receivables
OtherReceivables
311000 usd
CY2023Q4 us-gaap Other Receivables
OtherReceivables
751000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12093000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
25752000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
240500000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
407063000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
100902000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
108309000 usd
CY2022Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
195542000 usd
CY2023Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
321913000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
335140000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
620667000 usd
CY2021 us-gaap Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1
AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1
19975000 usd
CY2022 us-gaap Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1
AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1
19811000 usd
CY2023 us-gaap Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1
AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1
22141000 usd
CY2021 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
2443000 usd
CY2022 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
1798000 usd
CY2023 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
504000 usd
CY2022Q4 mvst Cost Of Land Use Rights
CostOfLandUseRights
15143000 usd
CY2023 mvst Estimated Usage Term Period
EstimatedUsageTermPeriod
P50Y
CY2021 mvst Amortization Of Land Use Rights
AmortizationOfLandUseRights
325000 usd
CY2022 mvst Amortization Of Land Use Rights
AmortizationOfLandUseRights
310000 usd
CY2023 mvst Amortization Of Land Use Rights
AmortizationOfLandUseRights
294000 usd
CY2023 mvst Land Use Rights Expected Amortization Year Five
LandUseRightsExpectedAmortizationYearFive
294000 usd
CY2023 mvst Land Use Rights Expected Amortization Year Two
LandUseRightsExpectedAmortizationYearTwo
294000 usd
CY2023 mvst Land Use Rights Expected Amortization Year Three
LandUseRightsExpectedAmortizationYearThree
294000 usd
CY2023 mvst Land Use Rights Expected Amortization After Year Five
LandUseRightsExpectedAmortizationAfterYearFive
294000 usd
CY2023 mvst Land Use Rights Expected Amortization Year Four
LandUseRightsExpectedAmortizationYearFour
294000 usd
CY2023 mvst Land Use Rights Expected Amortization Year One
LandUseRightsExpectedAmortizationYearOne
294000 usd
CY2022 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
3493000 usd
CY2023 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
5472000 usd
CY2022 mvst Acquired Intangible Assets Accumulated Amortizations
AcquiredIntangibleAssetsAccumulatedAmortizations
1857000 usd
CY2023 mvst Acquired Intangible Assets Accumulated Amortizations
AcquiredIntangibleAssetsAccumulatedAmortizations
2336000 usd
CY2022 mvst Acquired Intangible Assets Net
AcquiredIntangibleAssetsNet
1636000 usd
CY2023 mvst Acquired Intangible Assets Net
AcquiredIntangibleAssetsNet
3136000 usd
CY2021 mvst Amortization Expense
AmortizationExpense
413000 usd
CY2022 mvst Amortization Expense
AmortizationExpense
244000 usd
CY2023 mvst Amortization Expense
AmortizationExpense
493000 usd
CY2022 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
CY2023 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
CY2021 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
488000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
484000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
482000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
476000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
385000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
821000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3136000 usd
CY2022Q4 mvst Payables For Purchase Of Property Plant And Equipment
PayablesForPurchaseOfPropertyPlantAndEquipment
29183000 usd
CY2023Q4 mvst Payables For Purchase Of Property Plant And Equipment
PayablesForPurchaseOfPropertyPlantAndEquipment
96350000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8608000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
14312000 usd
CY2022Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
13044000 usd
CY2023Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
13738000 usd
CY2022Q4 mvst Accrued Payroll And Welfare
AccruedPayrollAndWelfare
4716000 usd
CY2023Q4 mvst Accrued Payroll And Welfare
AccruedPayrollAndWelfare
8089000 usd
CY2022Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current And Noncurrent
AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
6296000 usd
CY2023Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current And Noncurrent
AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
7117000 usd
CY2022Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
2641000 usd
CY2023Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
6224000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1934000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2413000 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
298000 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
41000 usd
CY2022Q4 mvst Accrued Expense And Other Liabilities Current
AccruedExpenseAndOtherLiabilitiesCurrent
66720000 usd
CY2023Q4 mvst Accrued Expense And Other Liabilities Current
AccruedExpenseAndOtherLiabilitiesCurrent
148284000 usd
CY2020Q4 mvst Movement Of Product Warranty Opening Balance
MovementOfProductWarrantyOpeningBalance
19356000 usd
CY2021Q4 mvst Movement Of Product Warranty Opening Balance
MovementOfProductWarrantyOpeningBalance
58458000 usd
CY2022Q4 mvst Movement Of Product Warranty Opening Balance
MovementOfProductWarrantyOpeningBalance
42060000 usd
CY2021 mvst Warranty Expense Provided During The Period
WarrantyExpenseProvidedDuringThePeriod
52932000 usd
CY2022 mvst Warranty Expense Provided During The Period
WarrantyExpenseProvidedDuringThePeriod
14097000 usd
CY2023 mvst Warranty Expense Provided During The Period
WarrantyExpenseProvidedDuringThePeriod
12688000 usd
CY2021 mvst Utilization Of The Product Warranty During The Period
UtilizationOfTheProductWarrantyDuringThePeriod
13830000 usd
CY2022 mvst Utilization Of The Product Warranty During The Period
UtilizationOfTheProductWarrantyDuringThePeriod
26916000 usd
CY2023 mvst Utilization Of The Product Warranty During The Period
UtilizationOfTheProductWarrantyDuringThePeriod
18379000 usd
CY2021 mvst Exchange Difference Of The Product Warranty During The Period
ExchangeDifferenceOfTheProductWarrantyDuringThePeriod
0 usd
CY2022 mvst Exchange Difference Of The Product Warranty During The Period
ExchangeDifferenceOfTheProductWarrantyDuringThePeriod
-3579000 usd
CY2023 mvst Exchange Difference Of The Product Warranty During The Period
ExchangeDifferenceOfTheProductWarrantyDuringThePeriod
-1152000 usd
CY2021Q4 mvst Movement Of Product Warranty Ending Balance
MovementOfProductWarrantyEndingBalance
58458000 usd
CY2022Q4 mvst Movement Of Product Warranty Ending Balance
MovementOfProductWarrantyEndingBalance
42060000 usd
CY2023Q4 mvst Movement Of Product Warranty Ending Balance
MovementOfProductWarrantyEndingBalance
35217000 usd
CY2021Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
20922000 usd
CY2022Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
13044000 usd
CY2023Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
13738000 usd
CY2021Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
37536000 usd
CY2022Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
29016000 usd
CY2023Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
21479000 usd
CY2021 mvst Warrants Expense
WarrantsExpense
46485000 usd
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
465000 usd
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
6171000 usd
CY2022 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
492000 usd
CY2023 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
1503000 usd
CY2020Q4 mvst Bank Borrowings Beginning Balance
BankBorrowingsBeginningBalance
12184000 usd
CY2021Q4 mvst Bank Borrowings Beginning Balance
BankBorrowingsBeginningBalance
13301000 usd
CY2022Q4 mvst Bank Borrowings Beginning Balance
BankBorrowingsBeginningBalance
46395000 usd
CY2021 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
38926000 usd
CY2022 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
58708000 usd
CY2023 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
47852000 usd
CY2021 mvst Repayments Of Principal
RepaymentsOfPrincipal
37568000 usd
CY2022 mvst Repayments Of Principal
RepaymentsOfPrincipal
24482000 usd
CY2023 mvst Repayments Of Principal
RepaymentsOfPrincipal
14119000 usd
CY2021 mvst Exchange Difference
ExchangeDifference
-241000 usd
CY2022 mvst Exchange Difference
ExchangeDifference
-1132000 usd
CY2023 mvst Exchange Difference
ExchangeDifference
-975000 usd
CY2021Q4 mvst Bank Borrowings Ending Balance
BankBorrowingsEndingBalance
13301000 usd
CY2022Q4 mvst Bank Borrowings Ending Balance
BankBorrowingsEndingBalance
46395000 usd
CY2023Q4 mvst Bank Borrowings Ending Balance
BankBorrowingsEndingBalance
79153000 usd
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
17398000 usd
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
35392000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
28997000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
43761000 usd
CY2022Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
46395000 usd
CY2023Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
79153000 usd
CY2022Q4 mvst Pledged Buildings
PledgedBuildings
27245000 usd
CY2023Q4 mvst Pledged Buildings
PledgedBuildings
124565000 usd
CY2022Q4 mvst Pledged Land Use Rights
PledgedLandUseRights
12639000 usd
CY2023Q4 mvst Pledged Land Use Rights
PledgedLandUseRights
11984000 usd
CY2022Q4 mvst Pledged Total Asset
PledgedTotalAsset
39884000 usd
CY2023Q4 mvst Pledged Total Asset
PledgedTotalAsset
136549000 usd
CY2022Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
29016000 usd
CY2023Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
21479000 usd
CY2022Q4 mvst Deferred Subsidy Income Noncurrent
DeferredSubsidyIncomeNoncurrent
3066000 usd
CY2023Q4 mvst Deferred Subsidy Income Noncurrent
DeferredSubsidyIncomeNoncurrent
3382000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
32082000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
24861000 usd
CY2022Q4 mvst Long Term Bonds Payable
LongTermBondsPayable
43888000 usd
CY2023Q4 mvst Long Term Bonds Payable
LongTermBondsPayable
43157000 usd
CY2018Q4 mvst Bond Loan
BondLoan
87776000 usd
CY2018Q4 mvst Bond Loan
BondLoan
600000000 cny
CY2018Q4 mvst Equity Holding Pledged Percentage
EquityHoldingPledgedPercentage
0.1239
CY2023 mvst Debt Instrument Convertible Amount Subsidiary Value Threshold
DebtInstrumentConvertibleAmountSubsidiaryValueThreshold
950000000 usd
CY2022Q4 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
14629000 usd
CY2022Q4 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
100000000 cny
CY2022Q4 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
14630000 usd
CY2022Q4 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
100000000 cny
CY2023Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.12
CY2023 mvst Repayments Of Bonds Payable
RepaymentsOfBondsPayable
692000 usd
CY2018Q4 mvst Aggregate Amount Of Bond Loan
AggregateAmountOfBondLoan
73147000 usd
CY2018Q4 mvst Aggregate Amount Of Bond Loan
AggregateAmountOfBondLoan
500000000 cny
CY2020Q4 mvst Subscribed By Bond Holders
SubscribedByBondHolders
29915000 usd
CY2020Q4 mvst Subscribed By Bond Holders
SubscribedByBondHolders
204500000 cny
CY2021Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
6719845 shares
CY2021Q1 mvst Purchase Agreement To Issue Convertible Promissory Note Amount
PurchaseAgreementToIssueConvertiblePromissoryNoteAmount
57500000 usd
CY2022Q2 mvst Interest Rate
InterestRate
0.06
CY2021 mvst Gain Loss On Changes In Fair Value Of Convertible Notes
GainLossOnChangesInFairValueOfConvertibleNotes
-9861000 usd
CY2021Q3 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
6736106 shares
CY2021Q3 us-gaap Stock Issued During Period Shares Purchase Of Assets
StockIssuedDuringPeriodSharesPurchaseOfAssets
27600000 shares
CY2021Q3 mvst Class Of Warrant Or Right Exercisable Period
ClassOfWarrantOrRightExercisablePeriod
P30D
CY2021Q3 mvst Class Of Warrant Or Right Registration Completion Period
ClassOfWarrantOrRightRegistrationCompletionPeriod
P90D
CY2021Q3 mvst Warrant Term
WarrantTerm
P5Y
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
231420000 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
71197000 usd
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
302617000 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
126000 usd
CY2022Q4 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
126000 usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
44541000 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
43648000 usd
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
88189000 usd
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
67000 usd
CY2023Q4 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
67000 usd
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1105000 usd
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
126000 usd
CY2022 mvst Assumed Warrant Liability Upon Merger
AssumedWarrantLiabilityUponMerger
0 usd
CY2023 mvst Assumed Warrant Liability Upon Merger
AssumedWarrantLiabilityUponMerger
0 usd
CY2023 mvst Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List Not Disclosed Flag
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag
true
CY2022 mvst Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List Not Disclosed Flag
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag
true
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
979000 usd
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
59000 usd
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
126000 usd
CY2023Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
67000 usd
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
3663000 usd
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
435000 usd
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P10Y2M12D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.052
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
3633000 usd
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
5725000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3341000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2822000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2567000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2437000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1861000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
11818000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
24846000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
5346000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
19500000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Tax Holidays
EffectiveIncomeTaxRateReconciliationTaxHolidays
0.80
CY2023 us-gaap Effective Income Tax Rate Reconciliation Tax Holidays
EffectiveIncomeTaxRateReconciliationTaxHolidays
0.80
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
33000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-98821000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-116353000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-101077000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-107662000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-41814000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-5325000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-206483000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-158167000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-106402000 usd
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
33000 usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
10000 usd
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
33000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
54459000 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
67569000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
3311000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
1385000 usd
CY2022Q4 mvst Deferred Tax Assets Product Warranty
DeferredTaxAssetsProductWarranty
6309000 usd
CY2023Q4 mvst Deferred Tax Assets Product Warranty
DeferredTaxAssetsProductWarranty
5306000 usd
CY2022Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
1367000 usd
CY2023Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
282000 usd
CY2022Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
334000 usd
CY2023Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
397000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
235000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
669000 usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
838000 usd
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
615000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
66853000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
76223000 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
37287000 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
55100000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
66853000 usd
CY2021 mvst Deferred Tax Assets Valuation Allowance Additions
DeferredTaxAssetsValuationAllowanceAdditions
17912000 usd
CY2022 mvst Deferred Tax Assets Valuation Allowance Additions
DeferredTaxAssetsValuationAllowanceAdditions
11838000 usd
CY2023 mvst Deferred Tax Assets Valuation Allowance Additions
DeferredTaxAssetsValuationAllowanceAdditions
12725000 usd
CY2021 mvst Deferred Tax Assets Valuation Allowance Reversal
DeferredTaxAssetsValuationAllowanceReversal
99000 usd
CY2022 mvst Deferred Tax Assets Valuation Allowance Reversal
DeferredTaxAssetsValuationAllowanceReversal
85000 usd
CY2023 mvst Deferred Tax Assets Valuation Allowance Reversal
DeferredTaxAssetsValuationAllowanceReversal
3355000 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
55100000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
66853000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
76223000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 mvst Loss Before Incomes Taxes
LossBeforeIncomesTaxes
-206483000 usd
CY2022 mvst Loss Before Incomes Taxes
LossBeforeIncomesTaxes
-158167000 usd
CY2023 mvst Loss Before Incomes Taxes
LossBeforeIncomesTaxes
-106402000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-43361000 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-33214000 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-22343000 usd
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
17408000 usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
20098000 usd
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
13644000 usd
CY2021 mvst Effective Income Tax Rate Reconciliation Permanent Differences Amount
EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount
-1411000 usd
CY2022 mvst Effective Income Tax Rate Reconciliation Permanent Differences Amount
EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount
-4295000 usd
CY2023 mvst Effective Income Tax Rate Reconciliation Permanent Differences Amount
EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount
-220000 usd
CY2021 mvst Effective Income Tax Rate Reconciliation Tax Effect Of Income Tax Rate Difference In Other Jurisdiction Amount
EffectiveIncomeTaxRateReconciliationTaxEffectOfIncomeTaxRateDifferenceInOtherJurisdictionAmount
6287000 usd
CY2022 mvst Effective Income Tax Rate Reconciliation Tax Effect Of Income Tax Rate Difference In Other Jurisdiction Amount
EffectiveIncomeTaxRateReconciliationTaxEffectOfIncomeTaxRateDifferenceInOtherJurisdictionAmount
1657000 usd
CY2023 mvst Effective Income Tax Rate Reconciliation Tax Effect Of Income Tax Rate Difference In Other Jurisdiction Amount
EffectiveIncomeTaxRateReconciliationTaxEffectOfIncomeTaxRateDifferenceInOtherJurisdictionAmount
-1411000 usd
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
21077000 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
15754000 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
10330000 usd
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
0 usd
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
33000 usd
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
10000 usd
CY2021 mvst Effective Income Tax Rate Reconciliation Income Tax Expenses Amount
EffectiveIncomeTaxRateReconciliationIncomeTaxExpensesAmount
0 usd
CY2022 mvst Effective Income Tax Rate Reconciliation Income Tax Expenses Amount
EffectiveIncomeTaxRateReconciliationIncomeTaxExpensesAmount
33000 usd
CY2023 mvst Effective Income Tax Rate Reconciliation Income Tax Expenses Amount
EffectiveIncomeTaxRateReconciliationIncomeTaxExpensesAmount
10000 usd
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
381636000 usd
CY2023Q4 mvst Remaining Operating Loss
RemainingOperatingLoss
114053000 usd
CY2017Q1 mvst Noncontrolling Interest Percentage
NoncontrollingInterestPercentage
0.1739
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
400000000 usd
CY2018Q1 mvst Redemption Of Noncontrolling Equity Interest Percentage
RedemptionOfNoncontrollingEquityInterestPercentage
0.1405
CY2018Q1 mvst Simple Annual Interest
SimpleAnnualInterest
0.0600
CY2021Q1 mvst Payments To Exiting Investors
PaymentsToExitingInvestors
30000000 usd
CY2021Q3 mvst Convertible Of Common Shares
ConvertibleOfCommonShares
17253182 shares
CY2022Q4 mvst Investments In Affiliates Subsidiaries Associates And Joint Venture
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVenture
7246000 usd
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-76000 usd
CY2023Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
800000000 shares
CY2023Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2023 mvst Designated As Common Stock Shares
DesignatedAsCommonStockShares
750000000 shares
CY2023 mvst Designated As Redeemable Convertible Preferred Stock
DesignatedAsRedeemableConvertiblePreferredStock
50000000 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
300516237 shares
CY2021Q3 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2021Q3 mvst Common Stock Voting Rights Number Of Votes
CommonStockVotingRightsNumberOfVotes
1 vote
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
316694442 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
315006942 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
36091071 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.08
CY2022Q4 mvst Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue
4.80
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y9M18D
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
640000 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.77
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.18
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
3854389 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.93
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
4.79
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
32876682 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.01
CY2023Q4 mvst Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue
4.73
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y8M12D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
32876682 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
6.01
CY2023Q4 mvst Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest And Exercisable Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestAndExercisableWeightedAverageGrantDateFairValue
4.73
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y8M12D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
21366586 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.11
CY2023Q4 mvst Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue
4.85
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y9M18D
CY2023 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
29708000 usd
CY2023 us-gaap Net Amount At Risk By Product And Guarantee Weighted Average Period Remaining1
NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1
P0Y8M12D
CY2023Q4 mvst Aggregate Intrinsic Value Of The Share Options
AggregateIntrinsicValueOfTheShareOptions
10000 usd
CY2023 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
2839000 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
5282000 usd
CY2021 mvst Share Based Compensation Cost Of Sales
ShareBasedCompensationCostOfSales
4309000 usd
CY2022 mvst Share Based Compensation Cost Of Sales
ShareBasedCompensationCostOfSales
7712000 usd
CY2023 mvst Share Based Compensation Cost Of Sales
ShareBasedCompensationCostOfSales
6091000 usd
CY2021 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
59492000 usd
CY2022 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
67261000 usd
CY2023 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
43831000 usd
CY2021 us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
13064000 usd
CY2022 us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
13987000 usd
CY2023 us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
11103000 usd
CY2021 us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
6029000 usd
CY2022 us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
6745000 usd
CY2023 us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
3946000 usd
CY2021 mvst Share Based Compensation Construction In Process
ShareBasedCompensationConstructionInProcess
237000 usd
CY2022 mvst Share Based Compensation Construction In Process
ShareBasedCompensationConstructionInProcess
525000 usd
CY2023 mvst Share Based Compensation Construction In Process
ShareBasedCompensationConstructionInProcess
343000 usd
CY2021 mvst Stock Based Compensation Total
StockBasedCompensationTotal
83131000 usd
CY2022 mvst Stock Based Compensation Total
StockBasedCompensationTotal
96230000 usd
CY2023 mvst Stock Based Compensation Total
StockBasedCompensationTotal
65314000 usd
CY2021 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
2774000 usd
CY2022 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
3370000 usd
CY2023 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
3552000 usd
CY2023 mvst Reserve Percentage
ReservePercentage
0.10
CY2023 mvst Registered Capital Percentage
RegisteredCapitalPercentage
0.50
CY2022Q4 mvst Restricted Net Asset
RestrictedNetAsset
523087000 usd
CY2023Q4 mvst Restricted Net Asset
RestrictedNetAsset
528337000 usd
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2022Q4 us-gaap Noncurrent Assets
NoncurrentAssets
347779000 usd
CY2022Q4 mvst Long Lived Assets Percentage
LongLivedAssetsPercentage
1
CY2023Q4 us-gaap Noncurrent Assets
NoncurrentAssets
632651000 usd
CY2023Q4 mvst Long Lived Assets Percentage
LongLivedAssetsPercentage
1
CY2021 us-gaap Revenues
Revenues
151976000 usd
CY2021 mvst Revenues Percentage
RevenuesPercentage
1
CY2022 us-gaap Revenues
Revenues
204495000 usd
CY2022 mvst Revenues Percentage
RevenuesPercentage
1
CY2023 us-gaap Revenues
Revenues
306617000 usd
CY2023 mvst Revenues Percentage
RevenuesPercentage
1
CY2021 mvst Loans From Related Parties
LoansFromRelatedParties
8426000 usd
CY2022 mvst Loans From Related Parties
LoansFromRelatedParties
0 usd
CY2023 mvst Loans From Related Parties
LoansFromRelatedParties
0 usd
CY2022Q4 mvst Outstanding Balance Due From Related Party
OutstandingBalanceDueFromRelatedParty
0 usd
CY2021 mvst Net Income Loss Available To Common Stockholders
NetIncomeLossAvailableToCommonStockholders
-234103000 usd
CY2022 mvst Net Income Loss Available To Common Stockholders
NetIncomeLossAvailableToCommonStockholders
-158200000 usd
CY2023 mvst Net Income Loss Available To Common Stockholders
NetIncomeLossAvailableToCommonStockholders
-106336000 usd
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
185896482 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
185896482 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
303279188 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
303279188 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
310909379 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
310909379 shares
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.26
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.26
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.52
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.52
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
CY2021 mvst Shares Issuable Upon Exercise Of Share Options
SharesIssuableUponExerciseOfShareOptions
33786356 shares
CY2022 mvst Shares Issuable Upon Exercise Of Share Options
SharesIssuableUponExerciseOfShareOptions
35244877 shares
CY2023 mvst Shares Issuable Upon Exercise Of Share Options
SharesIssuableUponExerciseOfShareOptions
35572123 shares
CY2021 mvst Shares Issuable Upon Vesting Of Non Vested Shares
SharesIssuableUponVestingOfNonVestedShares
167268 shares
CY2022 mvst Shares Issuable Upon Vesting Of Non Vested Shares
SharesIssuableUponVestingOfNonVestedShares
1399711 shares
CY2023 mvst Shares Issuable Upon Vesting Of Non Vested Shares
SharesIssuableUponVestingOfNonVestedShares
3623777 shares
CY2021 mvst Shares Issuable Upon Exercise Of Capped Non Vested Shares
SharesIssuableUponExerciseOfCappedNonVestedShares
0 shares
CY2022 mvst Shares Issuable Upon Exercise Of Capped Non Vested Shares
SharesIssuableUponExerciseOfCappedNonVestedShares
7314598 shares
CY2023 mvst Shares Issuable Upon Exercise Of Capped Non Vested Shares
SharesIssuableUponExerciseOfCappedNonVestedShares
10393732 shares
CY2021 mvst Shares Issuable Upon Exercise Of Warrants
SharesIssuableUponExerciseOfWarrants
12543444 shares
CY2022 mvst Shares Issuable Upon Exercise Of Warrants
SharesIssuableUponExerciseOfWarrants
28437000 shares
CY2023 mvst Shares Issuable Upon Exercise Of Warrants
SharesIssuableUponExerciseOfWarrants
28437000 shares
CY2021 mvst Shares Issuable Upon Conversion Of Noncontrolling Interests Subsidiary
SharesIssuableUponConversionOfNoncontrollingInterestsSubsidiary
9595605 shares
CY2022 mvst Shares Issuable Upon Conversion Of Noncontrolling Interests Subsidiary
SharesIssuableUponConversionOfNoncontrollingInterestsSubsidiary
0 shares
CY2023 mvst Shares Issuable Upon Conversion Of Noncontrolling Interests Subsidiary
SharesIssuableUponConversionOfNoncontrollingInterestsSubsidiary
0 shares
CY2021 mvst Shares Issuable Upon Vesting Of Earnout Shares
SharesIssuableUponVestingOfEarnoutShares
8821913 shares
CY2022 mvst Shares Issuable Upon Vesting Of Earnout Shares
SharesIssuableUponVestingOfEarnoutShares
19999988 shares
CY2023 mvst Shares Issuable Upon Vesting Of Earnout Shares
SharesIssuableUponVestingOfEarnoutShares
19999988 shares
CY2021 mvst Shares Issuable That May Be Subject To Cancellation In Shares
SharesIssuableThatMayBeSubjectToCancellationInShares
744349 shares
CY2022 mvst Shares Issuable That May Be Subject To Cancellation In Shares
SharesIssuableThatMayBeSubjectToCancellationInShares
1687500 shares
CY2023 mvst Shares Issuable That May Be Subject To Cancellation In Shares
SharesIssuableThatMayBeSubjectToCancellationInShares
1687500 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
309316011 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
316694442 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
307628511 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
315006942 shares
CY2023 dei Auditor Firm
AuditorFirmId
1113

Files In Submission

Name View Source Status
0001760689-24-000007-index-headers.html Edgar Link pending
0001760689-24-000007-index.html Edgar Link pending
0001760689-24-000007.txt Edgar Link pending
0001760689-24-000007-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mvst-20231231.htm Edgar Link pending
mvst-20231231.xsd Edgar Link pending
mvst-20231231_g1.jpg Edgar Link pending
mvst-arclawbackpolicy.htm Edgar Link pending
mvst-arclawbackpolicy001.jpg Edgar Link pending
mvst-arclawbackpolicy002.jpg Edgar Link pending
mvst-arclawbackpolicy003.jpg Edgar Link pending
mvst20221231-ex2112.htm Edgar Link pending
mvst20221231-ex3112.htm Edgar Link pending
mvst20221231-ex412.htm Edgar Link pending
mvst20231231-ex231.htm Edgar Link pending
mvst20231231-ex312.htm Edgar Link pending
mvst20231231-ex321.htm Edgar Link pending
mvst20231231-ex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R112.htm Edgar Link pending
R113.htm Edgar Link pending
R114.htm Edgar Link pending
R115.htm Edgar Link pending
R116.htm Edgar Link pending
R117.htm Edgar Link pending
R118.htm Edgar Link pending
R119.htm Edgar Link pending
R12.htm Edgar Link pending
R120.htm Edgar Link pending
R121.htm Edgar Link pending
R122.htm Edgar Link pending
mvst-20231231_cal.xml Edgar Link unprocessable
mvst-20231231_pre.xml Edgar Link unprocessable
mvst-20231231_def.xml Edgar Link unprocessable
mvst-20231231_lab.xml Edgar Link unprocessable
mvst-20231231_htm.xml Edgar Link completed
R123.htm Edgar Link pending
R124.htm Edgar Link pending
R125.htm Edgar Link pending
R126.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable